Skip to main content

Full Schedule

Full Schedule

  • Friday, May 5, 2023
  • 8:45 AM – 9:00 AM ET
    Welcome
  • 9:00 AM – 9:45 AM ET
    Session 8: The Uncommon Tumors of the Thorax
  • 9:45 AM – 9:52 AM ET
    Session 9: Debate: How to Handle PD-L1 <1% - Chemo + IO
    Presenter: Marina Garassino, MD – University of Chicago
  • 9:52 AM – 9:59 AM ET
    Session 9: Debate: How to Handle PD-L1 <1% - IO Combos
    Presenter: Mary Fidler, MD – Rush University Medical Center
  • 9:59 AM – 10:06 AM ET
    Session 9: Debate: How to Handle PD-L1 1-49% - Chemo + IO
    Presenter: Marina Garassino, MD – University of Chicago
  • 10:06 AM – 10:13 AM ET
    Session 9: Debate: How to Handle PD-L1 1-49% - IO Only
    Presenter: Mary Fidler, MD – Rush University Medical Center
  • 10:13 AM – 10:30 AM ET
    Session 9: Debates: How to Handle PD-L1
    Session Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania
    Panelist: Marina Garassino, MD – University of Chicago
    Panelist: Mary Fidler, MD – Rush University Medical Center
  • 10:30 AM – 11:00 AM ET
    Exhibit Hall
  • 11:00 AM – 11:45 AM ET
    Session 10: Updates from Recent Meetings
  • 11:45 AM – 12:30 PM ET
    Session 11: Unique Immune Combinations with Checkpoint Inhibitors
    Presenter: Marina Garassino, MD – University of Chicago
  • 12:30 PM – 1:30 PM ET
    Lunch
  • 1:30 PM – 1:37 PM ET
    Session 12: Debate: How to Handle PD-L1 >50% - Chemo + IO
  • 1:37 PM – 1:44 PM ET
    Session 12: Debate: How to Handle PD-L1 >50% - IO Only
  • 1:44 PM – 1:51 PM ET
    Session 12: Debate: Neoadjuvant vs Adjuvant Therapy - Neoadjuvant
  • 1:51 PM – 1:58 PM ET
    Session 12: Debate: Neoadjuvant vs Adjuvant Therapy - Adjuvant
  • 1:58 PM – 2:15 PM ET
    Session 12: Debates: How to Handle PD-L1 and Neoadjuvant vs Adjuvant Therapy
  • 2:15 PM – 3:00 PM ET
    Session 13: Advancing the Management of NSCLC: A Focus on Emerging Therapies
    Presenter: Ticiana Leal, MD – Emory University
  • 3:00 PM – 3:30 PM ET
    Exhibit Hall
  • 3:30 PM – 4:15 PM ET
    Session 14: KRAS Mutations: Taming a "Defiant" Oncogene in NSCLC
  • 4:15 PM – 5:00 PM ET
    Session 15: BRAF Mutations: Identifying and Addressing a Rare Oncogenic Driver
    Presenter: Edgardo Santos, MD – Genesis Care US